All News In the News News Releases

In Memoriam

Thomas B. Graboys, MD  The Lown Institute family mourns the loss of Thomas B. Graboys, MD, president emeritus of the Institute and former director of the Lown Cardiovascular Center, who died on January 5. Dr. Graboys was a senior physician at the Brigham and Women’s Hospital and a professor of medicine at Harvard Medical School. […]

Read More

Still standing up after sitting in

January 12, 2015

By Margie Coloian

Anybody who followed the controversy over the diabetes drug rosiglitazone (trade name Avandia) knows that Dr. Steve Nissen played a central role in the Food and Drug Administration’s decision to issue a warning about the drug’s cardiovascular risks. He was also involved in blowing the whistle in 2001 in identifying the cardiovascular risk of the pain medication Vioxx. But Nissen’s history of activism began long before.

Read More



A better flu shot for the elderly? High dose flu vaccine as a breakthrough?

By Andy Lazris, MD
December 21, 2014

Should high dose flu shots be used in the elderly? The New York Times said it best, mirroring the chorus of praise in the press after a major study evaluated the efficacy of high dose flu vaccine in the elderly compared to standard dose: “Now a study, published recently in The New England Journal of Medicine, finds that Fluzone High-Dose does indeed prevent influenza in older adults, reducing cases of the flu by 24 percent compared with the standard version.”

Read More



Should hospitals be part of the solution?

By Andy Lazris, MD
December 14, 2014

Recently someone shared with me an article, An Amazing Healthcare Revolution is Happening in Maryland, written by Brett Logiurato in Business Insider. The revolution, it seems, is triggered by changes in hospitals that are encouraging fewer admissions and better communication. Under Maryland’s Total Payment Revenue Budget Cap, Maryland hospitals are capitated by Medicare; they earn just as much if they do not admit patients than if they do.

Read More